1. Executive Summary

2. United States Anesthesia Drugs Market

3. Market Share – United States Anesthesia Drugs
3.1 Anesthesia Drugs
3.2 General Intravenous Anesthesia Drugs
3.3 Local Anesthesia Drugs
3.4 Company

4. Market – United States Anesthesia Drugs Types
4.1 General Inhalation Anesthesia Drugs Market
4.2 General Intravenous Anesthesia Drugs Market
4.3 Local Anesthesia Drugs Market

5. Market – General Intravenous Anesthesia Drugs
5.1 Propofol
5.2 Benzodiazepines Class (Diazepam and Midazolam)
5.3 Fospropofol Disodium
5.4 Ketamine
5.5 Methohexital Sodium
5.6 Pentobarbital
5.7 Etomidate
5.8 Fentanyl

6. Market – Local Anesthesia Drugs
6.1 Articaine
6.2 Bupivacaine
6.3 Lidocaine
6.4 Mepivacaine
6.5 Prilocaine

7. Companies - United States Anesthesia Drugs Market
7.1 Baxter International Inc. Anesthesia Drugs Sales
7.2 Endo International plc Anesthesia Drugs Sales
7.3 AbbVie Anesthesia Drugs Sales
7.4 Other Companies Anesthetic Drugs Sales

8. Merger & Acquisition (M&A) – United States Anesthesia

9. Reimbursement Policy - Private Health Insurance Providers
9.1 Aetna International
9.2 Coventry Health Care
9.3 Anthem Blue Cross and Blue Shield
9.4 Blue Cross and Blue Shield of Texas
9.5 UnitedHealthcare
9.5.1 State Exceptions

10. Reimbursement Policy – Public Health Insurance Providers
10.1 Medicare
10.2 MDWise

11. Growth Drivers
11.1 Growing Demand for Anesthesia Service
11.2 Rise in Ageing Population & Prevalence of Cardiovascular Disease in United States

12. Challenges
12.1 Un-match Anesthesia Providers in United States
12.2 Shortage of Anesthesia Drugs in United States